Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

spacer.gif (43 bytes)

FOOD AND DRUG ADMINISTRATION
FOR IMMEDIATE RELEASE

Consumer Media: 888-Info-FDA
April 28, 1999

Mova Pharmaceutical Corporation Recalls Levothyroxine Sodium Tablets

PRODUCT
Levothyroxine Sodium Tablets, USP, 0.025 MG; 0.050 MG; 0.075 MG; 0.088 MG; 0.100 MG; 0.112 MG; 0.125 MG; 0.150 MG; 0.175 MG; 0.200 MG; 0.300 MG,. in bottles of 100 and 1,000 tablets, distributed under various private labels: Euthryrox - Em Pharma, Div Of Dey LabsLevothyroxine - Moore L-Thyroxine Sodium - Major Pharmaceuticals L-Thyroxine Sodium - Geneva Pharmaceuticals Levo-T - Pharma Science Levotec - Technilab L-Thyroxine Sodium - Harvard Drug L-Thyroxine Sodium - Logen Pharmaceuticals L-Thyroxine Sodium - Richie Pharmacal Euthryrox - Mova Interamerica. Recall #D-174/184-9.

CODE
Any lot number with the prefix(s) MPT, MST, or ST.

MANUFACTURER
Mova Pharmaceutical Corporation, Caguas, Puerto Rico.

RECALLED BY
Manufacturer, by letter dated February 25, 1999, followed by telephone or fax. Firm-initiated recall ongoing.

DISTRIBUTION
Nationwide and Canada.

QUANTITY
487,275 bottles were distributed.

REASON
Superpotency.

 

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.